A dual action of the adrenergic system on the release of LH has been demonstrated: facilitation mediated by α-adrenergic receptors and inhibition mediated by β-adrenergic receptors. These two actions can be dissociated either by treatment with agents which block-specific adrenergic receptors or by cuts placed just in front of the mammillary bodies (PM cuts) interrupting caudal afferents to the medial basal hypothalamus. These cuts affected the release of luteinizing hormone (LH) in a way similar to that of treatment with the β-adrenoblocker, propranolol. Thus, in animals with PM cuts (1) the release of LH following the injection of norepinephrine into the third ventricle was enhanced and (2) the blocking action of intraventricular injection of isoproterenol on the release of LH was suppressed whereas the facilitatory effect of clonidine was not changed. Furthermore, whereas the release of LH induced by intraventricular injection of norepinephrine in intact rats was enhanced by treatment with propranolol, in rats with PM cuts the already enhanced induced release was no further rised by propranolol treatment. On the other hand, PM cuts did not affect the suppressive action of the α-adrenoblocker phenoxybenzamine on the norepinephrine-induced release of LH. It is concluded that adrenergic mechanisms inhibiting the release of LH were suppressed by PM cuts whereas those facilitating the release were not affected by these cuts.

Keywords:
Hypothalamic deafferentation, Adrenergic agonists, Adrenergic antagonists, LH release
© 1982 S. Karger AG, Basel
1982
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.